Allogene Therapeutics Inc (ALLO)
Operating Expenses
$51.56M
Quarterly · Period ending: · USD
ALLO Operating Expenses
Latest reported$51.56Mperiod ending
Latest reported$51.56Mperiod ending
ALLO Quarterly Operating Expenses ($2.00K → $51.56M)
Quarterly operating expenses
High-resolution chart · PNG
ALLO operating expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 51,560,000 | |
| 46,092,000 | |
| 42,404,000 | |
| 44,901,000 | |
| 56,819,000 | |
| 65,191,000 | |
| 60,490,000 | |
| 71,774,000 | |
| 71,431,000 | |
| 65,971,000 | |
| 85,130,000 | |
| 59,446,000 | |
| 80,562,000 | |
| 99,122,000 | |
| 96,421,000 | |
| 82,538,000 | |
| 76,680,000 | |
| 80,053,000 | |
| 73,944,000 | |
| 77,719,000 | |
| 71,073,000 | |
| 71,546,000 | |
| 69,362,000 | |
| 68,040,000 | |
| 63,158,000 | |
| 57,683,000 | |
| 64,575,000 | |
| 55,011,000 | |
| 45,961,000 | |
| 36,461,000 | |
| 33,046,000 | |
| 22,187,000 | |
| 135,012,000 | |
| 2,597,000 | |
| 2,000 |